Immunalysis Corporation, in California, USA, tailors the Tecan Freedom EVO 75 liquid handing workstation as the platform of choice to provide customized semi and fully automated drugs of abuse screening solutions, including entire panels of test kits in ELISA format, to forensic toxicology laboratories.

Michael Vincent, Vice President of Operations at Immunalysis, explained: “The Freedom EVO 75 workstation is a robust instrument with excellent sample and error tracking properties that give our customers the accuracy and safety assurances that are vital for their work, because their results can have a direct bearing on the verdict in a court of law. Our screening solutions typically process 24 to 96 samples and controls in each run, using panels of six to fifteen assays; when so many samples are going through multiple assays, the integrity of the testing is critical and the Freedom EVO 75 maintains this admirably.”

Michael concluded: “A significant advantage of Tecan’s Freedom EVO family of instruments is that, once configured, the same software and characteristics can be extrapolated to larger platforms in the same series so systems can easily be upgraded if throughput requirements grow, with minimal re-training of operators.”

About Tecan

Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).

For further information please contact:

Tecan Group Ltd.
Cornelia Kegele
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12
www.tecan.com